ALLR - Company ID 0001860657
The table below shows Allarity Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $16.98M | $19.81M | $16.89M | $17.80M | $25.20M | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $31.73M |
| $34.50M |
| $20.47M |
| $20.88M |
| $29.42M |
| $20.37M |
| Property, plant & equipment | $386.00K | $420.00K | $330.00K | $322.00K | $308.00K | $12.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $32.12M | $34.92M | $20.80M | $21.20M | $29.73M | $20.38M |
| Accounts payable | $4.11M | $4.24M | $4.60M | $4.61M | $4.35M | $4.69M |
| Total current liabilities | $28.58M | $28.00M | $8.79M | $9.04M | $11.06M | $7.41M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $28.58M | $28.00M | $8.79M | $9.04M | $11.06M | $7.41M |
| Retained earnings | -$136.35M | -$132.95M | -$126.82M | -$124.02M | -$121.70M | -$111.51M |
| Total equity | $3.54M | $6.92M | $12.01M | $12.17M | $18.67M | $12.96M |